Details for New Drug Application (NDA): 070767
✉ Email this page to a colleague
NDA 070767 describes NIZORAL, which is a drug marketed by Janssen Pharma, Janssen Pharms, and Kramer, and is included in five NDAs. Additional details are available on the NIZORAL profile page.
The generic ingredient in NIZORAL is ketoconazole. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.
The generic ingredient in NIZORAL is ketoconazole. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.
Summary for 070767
| Tradename: | NIZORAL |
| Applicant: | Janssen Pharma |
| Ingredient: | ketoconazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070767
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
| Approval Date: | Nov 7, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
